InsidersTradesSigma
Oncopeptides AB (publ): directors' dealings · Finland · FIN-FSA
FI:oncopeptides-ab-publ-f250e8SE0009414576FI·FIN-FSAMcap 653M€Healthcare
Explore the full insider trade history of Oncopeptides AB (publ), a listed issuer based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Oncopeptides AB (publ) has published 1 insider filings. Market capitalisation: €652.5m. The latest transaction was filed on 20 March 2026 — Purchase. Among the most active insiders: Stefan Norin. The full history is openly available.
1
Insider Decl.
0
Thresholds
€431
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.71 €
Analyst consensus
1 analystsStrong buy
2.80 €Target 2.80 €(+64%)2.80 €
Income statement
Revenue71.1 M€
Gross profit68.7 M€97% margin
Net income−249.6 M€-350.9% margin
Valuation
PER (forward)17.1x
Beta-1.42
Balance sheet & cash
Market cap652.5 M€
Total debt139.4 M€
Free Cash Flow−222.9 M€
Profitability & ownership
ROA-74.3%
% insiders9.0%
% institutions9.3%
Last declaration on 20 March 2026
Declarations1 total
Executives●Purchase18FIN-FSA
€4313,000 shares@ €0.14370.0001% mcap100.0% of flow
Aktie
FI:A003X195-1·
Ideal exit: 14 Dec 2026 (T+270)
1 of 1 declaration